Transmembrane protein 158 (TMEM158) has been shown to be significantly upregulated in primary glioblastoma (GBM) compared to WHO grade II or III gliomas based on multiple cancer database analyses. The gene discussed is TMEM158; the disease is central nervous system cancer.